PIA
PFE icon

Piedmont Investment Advisors’s Pfizer PFE Stock Holding History

Piedmont Investment Advisors’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-435,915
Closed -$13.5M – 515
2020
Q1 		$13.5M Buy
435,915
+13,357
+3% +$455K 0.53% 36
2019
Q4 		$15.7M Buy
422,558
+324,314
+330% +$11.6M 0.54% 33
2019
Q3 		$3.35M Sell
98,244
-219,648
-69% -$7.99M 0.13% 165
2019
Q2 		$13.1M Sell
317,892
-7,868
-2% -$312K 0.52% 34
2019
Q1 		$13.1M Sell
325,760
-175,381
-35% -$7.02M 0.53% 34
2018
Q4 		$20.8M Sell
501,141
-6,621
-1% -$275K 0.99% 12
2018
Q3 		$21.2M Sell
507,762
-251,506
-33% -$9.68M 0.89% 13
2018
Q2 		$26.1M Sell
759,268
-612,488
-45% -$20.9M 1.26% 8
2018
Q1 		$46.2M Sell
1,371,756
-337,135
-20% -$11.6M 1.23% 14
2017
Q4 		$58.7M Buy
1,708,891
+1,915
+0.1% +$65.3K 1.18% 16
2017
Q3 		$57.8M Buy
1,706,976
+19,130
+1% +$615K 1.23% 14
2017
Q2 		$53.8M Sell
1,687,846
-809,256
-32% -$25.5M 1.19% 15
2017
Q1 		$81M Sell
2,497,102
-395,371
-14% -$12.5M 1.68% 8
2016
Q4 		$89.1M Buy
2,892,473
+145,668
+5% +$4.45M 1.83% 5
2016
Q3 		$88.3M Sell
2,746,805
-161,716
-6% -$5.41M 1.92% 7
2016
Q2 		$97.2M Buy
2,908,521
+1,156,540
+66% +$36.9M 2% 6
2016
Q1 		$49.3M Buy
1,751,981
+16,846
+1% +$481K 1.04% 24
2015
Q4 		$53.1M Sell
1,735,135
-1,009,007
-37% -$31.7M 1.12% 21
2015
Q3 		$81.8M Buy
2,744,142
+90,142
+3% +$2.89M 1.85% 4
2015
Q2 		$84.4M Buy
2,654,000
+1,333,802
+101% +$43.5M 1.79% 4
2015
Q1 		$43.6M Sell
1,320,198
-70,603
-5% -$2.24M 2.67% 7
2014
Q4 		$41.1M Sell
1,390,801
-718,015
-34% -$20.6M 2.48% 8
2014
Q3 		$59.2M Buy
2,108,816
+10,282
+0.5% +$289K 3.06% 4
2014
Q2 		$59.1M Sell
2,098,534
-14,695
-0.7% -$419K 3.09% 3
2014
Q1 		$64.4M Buy
2,113,229
+32,690
+2% +$975K 3.53% 2
2013
Q4 		$60.5M Sell
2,080,539
-396,699
-16% -$11.5M 3.24% 2
2013
Q3 		$67.5M Buy
2,477,238
+692,627
+39% +$18.8M 3.53% 1
2013
Q2 		$47.4M Buy
+1,784,611
New +$49.3M 2.13% 20

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Piedmont Investment Advisors's PFE Position: Q2 2020 in Review

Piedmont Investment Advisors sold out of Pfizer (PFE) in Q2 2020, closing a stake of 435,915 shares — an estimated $13.5M sold.

Piedmont Investment Advisors first reported a position in PFE in Q2 2013 and held it in 28 quarters. The position peaked at $97.2M in Q2 2016. 2,441 funds tracked by Wall St. Rank hold PFE as of Q2 2020.

  • Piedmont Investment Advisors reported no remaining Pfizer position as of Q2 2020 after selling out during the quarter.
  • Piedmont Investment Advisors sold 435,915 Pfizer shares in Q2 2020, an estimated $13.5M.
  • Piedmont Investment Advisors first reported a position in Pfizer in Q2 2013 and held it in 28 quarters.
  • Piedmont Investment Advisors's Pfizer position peaked at $97.2M in Q2 2016.
  • 2,441 funds tracked by Wall St. Rank held Pfizer as of Q2 2020.

Based on Piedmont Investment Advisors's 13F filing for Q2 2020.